Vimarsana
Biggest News Aggregation in the World

Page 39 - Umer Raffat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Umer Raffat Today - Breaking & Trending Today

Athenex, Inc. (ATNX) Q1 2021 Earnings Call Transcript - Vimarsana News

Athenex, Inc. (ATNX) Q1 2021 Earnings Call Transcript

Operator Welcome to the Q1 2021 Athenex, Inc. Earnings Conference Call. My name is Richard, and I'll be your operator for today's call. [Operator Instructions] I am now going to call over Mr. Steven Rubis, Senior Director, Investor Relations. Steven, you may begin. Steven Rubis -- Investor Relations Good morning, and thank you for joining our conference call. Today, we will provide an update on Athenex's business as well as a review of financial results for the first quarter of 2021. The news release detailing the results crossed the wire earlier this morning and is available on the company'...

Source: fool.com
China vaccine stocks rebound as Merkel opposes patent waiver - Vimarsana News

China vaccine stocks rebound as Merkel opposes patent waiver

FILE PHOTO: A medical worker prepares a dose of the "Comirnaty" Pfizer-BioNTech COVID-19 vaccine inside the exhibition palace transformed into a vaccination center in Nice as part of the coronavirus disease (COVID-19) vaccination campaign in France, April 29, 2021. REUTERS/Eric Gaillard SHARES of Covid-19 vaccine developers in Asia got some relief after the German Chancellor rejected a U.S. proposal to waive patent protections for coronavirus shots. Chinese vaccine makers rebounded after slumping on Thursday following the initial news that the U.S. would support discussions for a waiver of t...

Waiving Vaccine Patents Unlikely to Boost Supplies, Experts Say - Vimarsana News

Waiving Vaccine Patents Unlikely to Boost Supplies, Experts Say

Paul Sancya/AFP/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now. The hope is that it will allow other companies to make their own versions of established COVID-19 vaccines.  But many of the tricks to making Pfizer and Moderna's vaccines aren't found in patents, experts say. A move to override Moderna, Pfizer, and other companies' exclusive rights to their COVID-19 vaccines has sent the drug industry into a tizzy. The Biden Administration said Wednesday that it wo...

Teva Pharmaceutical Industries (TEVA) Q1 2021 Earnings Call Transcript - Vimarsana News

Teva Pharmaceutical Industries (TEVA) Q1 2021 Earnings Call Transcript

Operator Good day, and thank you for standing by, and welcome to the Teva Pharmaceutical first-quarter 2021 financial results conference call. [Operator instructions] Please be advised that today's conference is being recorded. [Operator instructions] I would now like to hand the conference over to your speaker today, Kevin Mannix, senior vice president, head of investor relations. Please go ahead, sir. Kevin Mannix -- Senior Vice President, Head of Investor Relations Thank you, Anette. And thank you, everyone, for joining us today to discuss Teva's first-quarter 2021 financial results. We h...

Source: fool.com
Amgen Inc (AMGN) Q1 2021 Earnings Call Transcript - Vimarsana News

Amgen Inc (AMGN) Q1 2021 Earnings Call Transcript

Amgen Inc (AMGN) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Amgen Inc (NASDAQ: AMGN) Operator My name is Erica, and I will be your conference facilitator today for Amgen's First Quarter 2021 Financial Results Conference Call. [Operator Instructions] I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.SPONSORED: 10 stocks we like better than Amgen When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, ...

Source: msn.com